Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,593
Closed -$202K 270
2024
Q1
$202K Buy
+2,593
New +$193K 0.02% 269
2023
Q4
Sell
-3,212
Closed -$223K 297
2023
Q3
$223K Sell
3,212
-856
-21% -$64.7K 0.02% 252
2023
Q2
$329K Sell
4,068
-366
-8% -$29.9K 0.02% 282
2023
Q1
$358K Sell
4,434
-1,069
-19% -$86.1K 0.02% 270
2022
Q4
$412K Buy
5,503
+639
+13% +$45.5K 0.04% 253
2022
Q3
$314K Buy
4,864
+238
+5% +$16.5K 0.03% 287
2022
Q2
$321K Sell
4,626
-545
-11% -$40.5K 0.03% 299
2022
Q1
$397K Buy
5,171
+1,252
+32% +$90K 0.03% 288
2021
Q4
$300K Buy
+3,919
New +$288K 0.02% 238

Other funds holding HOLX

American Trust's HOLX Position: Q2 2024 in Review

American Trust sold out of Hologic (HOLX) in Q2 2024, closing a stake of 2,593 shares — an estimated $202K sold.

American Trust first reported a position in HOLX in Q4 2021 and held it in 9 quarters. The position peaked at $412K in Q4 2022. 703 funds tracked by Wall St. Rank hold HOLX as of Q2 2024.

  • American Trust reported no remaining Hologic position as of Q2 2024 after selling out during the quarter.
  • American Trust sold 2,593 Hologic shares in Q2 2024, an estimated $202K.
  • American Trust first reported a position in Hologic in Q4 2021 and held it in 9 quarters.
  • American Trust's Hologic position peaked at $412K in Q4 2022.
  • 703 funds tracked by Wall St. Rank held Hologic as of Q2 2024.

Based on American Trust's 13F filing for Q2 2024, filed 12 Sep 2024.